ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
2.060,00
0,00
(0,00%)
Geschlossen 28 Januar 5:30PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
2.060,00
Gebot
2.052,00
Fragen
2.054,00
Volumen
0,00
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
2.060,00
Handelsbeginn
-
Letzte Trade
(O)
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

SGP Neueste Nachrichten

Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Ann

BOSTON, Nov. 1 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today reported two data presentations supporting response guided therapy with boceprevir combination therapy in...

U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma

KENILWORTH, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Schering-Plough Corp. (NYSE:SGP) announced today the U.S. Food and Drug Administration (FDA) has issued a complete response letter to the...

Critical Alerts for Cisco, Schering-Plough, BHP Billiton, Costco, and American Eagle Released by Seven Summits Research

CHICAGO, Oct. 30 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for CSCO, SGP, BHP, COST, and AEO. Seven Summits Strategic Investments' PriceWatch Alerts are available at...

Schering-Plough Highlights Boceprevir, Narlaprevir (SCH 900518) and PEGINTRON(R) Data at the American Association for the Study

KENILWORTH, N.J., Oct. 15 /PRNewswire-FirstCall/ -- Schering-Plough (NYSE: SGP) today announced that data on boceprevir, an investigational hepatitis C virus (HCV) protease inhibitor, will be...

Intervet/Schering-Plough Animal Health Announces Sponsorship Supporting Milk Producers In Malawi

BOXMEER, Netherlands, Oct. 8 /PRNewswire-FirstCall/ -- Intervet/Schering-Plough Animal Health today announced that it has initiated a multi-year sponsorship project, supporting the Shire...

Critical Alerts for Microsoft, Schering-Plough, Yamana Gold, Whole Foods, and Chalco Released by Seven Summits Research

CHICAGO, Oct. 7 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for MSFT, SGP, AUY, WFMI, and ACH. Seven Summits Strategic Investments' PriceWatch Alerts are available at...

SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Sym

KENILWORTH, N.J., July 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today announced that its investigational agent SAPHRIS(R) (asenapine) met the primary endpoint over one...

Schering-Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck

KENILWORTH, N.J., July 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today reported a proposed settlement, subject to Court approval, to resolve litigation seeking to...

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Ast

KENILWORTH, N.J., July 22 /PRNewswire-FirstCall/ -- Schering-Plough today announced that a New Drug Application (NDA) for a fixed-dose combination of mometasone furoate and formoterol fumarate...

Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa

Single-dose of investigational sustained follicle stimulant achieves similar efficacy to daily injections of follitropin beta given over a one week period in Phase III Study AMSTERDAM, July 1...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

SGP - Frequently Asked Questions (FAQ)

What is the current Supergroup share price?
The current share price of Supergroup is 2.060,00p
What is the 1 year trading range for Supergroup share price?
Supergroup has traded in the range of 0,00p to 0,00p during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
NFXNuformix Plc
0,115p
(84,00%)
169,13M
CHFChesterfield Resources Plc
0,40p
(32,45%)
276,93k
IMMImmupharma Plc
5,20p
(28,40%)
49,53M
SNGSynairgen Plc
2,70p
(24,14%)
2,31M
GOODGood Energy Group Plc
480,00p
(21,52%)
902,4k
DARDar Global Plc
US$ 6,00
(-22,83%)
6,98k
CLAICel Ai Plc
0,345p
(-21,59%)
28,34M
CTAICatenai Plc
0,21p
(-17,65%)
87,41M
GENIGenincode Plc
4,00p
(-16,67%)
1,44M
WBIWoodbois Limited
0,095p
(-15,56%)
222,83M
UKOGUk Oil & Gas Plc
0,0205p
(-4,65%)
802,36M
CLONClontarf Energy Plc
0,045p
(12,50%)
689,68M
SYMESupply@me Capital Plc
0,0025p
(-13,79%)
415,74M
TRPTower Resources Plc
0,0295p
(0,00%)
411,68M
NTVONativo Resources Plc
0,0021p
(0,00%)
324,32M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock